US and UK versions of the EQ-5D preference weights: Does choice of preference weights make a difference?

Quality of Life Research

Volumn 16, Issue 6, 2007, Pages 1065-1072

  Huang, I Chan ^a   Willke, Richard J ^b   Atkinson, Mark J ^c   Lenderking, William R ^b   Frangakis, Constantine ^d   Wu, Albert W ^d,e  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b PFIZER INC   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

EQ 5D; Health utility; Preference weights; Validity

Indexed keywords

ADULT; ARTICLE; BODY WEIGHT; CD4 LYMPHOCYTE COUNT; CORRELATION COEFFICIENT; FEMALE; HEALTH SURVEY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSYCHOMETRY; QUALITY OF LIFE; VIRUS LOAD;

ADULT; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; DELAVIRDINE; DIDANOSINE; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; GREAT BRITAIN; HIV INFECTIONS; HUMANS; MALE; PATIENT SATISFACTION; PSYCHOMETRICS; QUALITY OF LIFE; QUALITY-ADJUSTED LIFE YEARS; REVERSE TRANSCRIPTASE INHIBITORS; SICKNESS IMPACT PROFILE; UNITED STATES; VIRAL LOAD;

EID: 34547423802     PISSN: 09629343     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11136-007-9206-4     Document Type: Article

References (52)

1. Garratt, A., Schmidt, L., Mackintosh, A., Fitzpatrick, R. (2002). Quality of life measurement: Bibliographic study of patient assessed health outcome measures. BMJ, 324, 1417.
2. Neumann, P. J., Goldie, S. J., Weinstein, M. C. (2000). Preference-based measures in economic evaluation in health care. Annual Revision of Public Health, 21, 587-611.
3. The EuroQol Group. (1990). EuroQol: A new facility for the measurement of health-related quality of life. Health Policy, 16, 199-208.
4. Brooks, R. (1996). EuroQol: The current state of play. Health Policy, 37, 53-72.
5. Dolan, P. (1997). Modeling valuations for EuroQol health states. Medical Care, 35, 1095-1108.
6. Berry, J. W., Poortinga, Y. H., Segall, M. H., Dasen, P. R. (2002). Health behavior. In J. W Berry, Y. H. Poortinga, M. H. Segall, P. R. Dasen (Eds.), Cross-cultural psychology: Research and applications (2nd ed., pp. 423-455). Cambridge, UK: Cambridge University Press.
7. Diener, E., Suh, E. (1999). National differences in subjective well-being. In D. Kahneman, E. Diener, N. Schwarz (Eds.), Well-being : The foundations of hedonic psychology (pp. 434-450). New York: Russell Sage Foundation.
8. Inglehart, R., Klingemann, H. (2000). Genes, culture, democracy, and happiness. In E. Diener, E. M. Suh (Eds.), Well-being and quality of life (pp. 165-183). Cambridge, MA: MIT Press.
9. Guillemin, F., Bombardier, C., Beaton, D. (1993). Cross-cultural adaptation of health-related quality of life measures: Literature review and proposed guidelines. Journal of Clinical Epidemiology, 46, 1417-1432.
10. Hunt, S. M., Alonso, J., Bucquet, D., Niero, M., Wiklund, I., McKenna, S. (1991). Cross-cultural adaptation of health measures. European group for health management and quality of life assessment. Health Policy, 19, 33-44.
11. Kaplan, R. M., Feeny, D., Revicki, D. A. (1993). Methods for assessing relative importance in preference based outcome measures. Quality of Life Research, 2, 467-475.
12. Badia, X., Roset, M., Herdman, M., Kind, P. (2001). A comparison of United Kingdom and Spanish general population time trade-off values for EQ-5D health states. Medical Decision Making, 21, 7-16.
13. Busschbach, J., Weijnen, T., Nieuwenhuizen, M. et al (2003). A comparison of EQ-5D time trade-off values obtained in Germany, the United Kingdom, Spain. In R. G. Brooks, R. Rabin, F. De Charro (Eds.), The measurement and valuation of health status using EQ-5D : A European perspective (1st ed., pp. 143-165). Boston, MA: Kluwer Academic Publishers.
14. Greiner, W., Weijnen, T., Nieuwenhuizen, M. et al (2003). A single European currency for EQ-5D health states. results from a six-country study. The European Journal of Health Economics, 4, 222-231.
15. Wu, A. W., Jacobson, K. L., Frick, K. D. et al (2002). Validity and responsiveness of the Europol as a measure of health-related quality of life in people enrolled in an AIDS clinical trial. Quality of Life Research, 11, 273-282.
16. Lubetkin, E. I., Gold, M. R. (2003). Areas of decrement in health-related quality of life (HRQL): Comparing the SF-12, EQ-5D, and HUI 3. Quality of Life Research, 12, 1059-1067.
17. Franks, P., Lubetkin, E. I., Gold, M. R., Tancredi, D. J., Jia, H. (2004). Mapping the SF-12 to the EuroQol EQ-5D index in a national US sample. Medical Decision Making, 24, 247-254.
18. Lawrence, W. F., Fleishman, J. A. (2004). Predicting EuroQoL EQ-5D preference scores from the SF-12 health survey in a nationally representative sample. Medical Decision Making, 24, 160-169.
19. Oster, G., Harding, G., Dukes, E., Edelsberg, J., Cleary, P. D. (2005). Pain, medication use, and health-related quality of life in older persons with postherpetic neuralgia: Results from a population-based survey. Journal of Pain, 6, 356-363.
20. Jia, H., Lubetkin, E. I. (2005). The impact of obesity on health-related quality-of-life in the general adult US population. Journal of public Health, 27, 156-164.
21. Pickard, A. S., Johnson, J. A., Feeny, D. H., Shuaib, A., Carriere, K. C., Nasser, A. M. (2004). Agreement between patient and proxy assessments of health-related quality of life after stroke using the EQ-5D and health utilities index. Stroke, 35, 607-612.
22. Shaw, J. W., Johnson, J. A., Coons, S. J. (2005). US valuation of the EQ-5D health states: Development and testing of the D1 valuation model. Medical Care, 43, 203-220.
23. Johnson, J. A., Luo, N., Shaw, J. W., Kind, P., Coons, S. J. (2005). Valuations of EQ-5D health states: Are the united states and united kingdom different?. Medical Care, 43, 221-228.
24. Nunnally, J. C., Bernstein, I. H. (1994). Construction of conventional tests. In J. C. Nunnally, I. H. Bernstein (Eds.), McGraw-Hill series in psychology (3rd ed. pp. 293-337). New York: McGraw-Hill.
25. Prieto, L., Alonso, J., Viladrich, M. C., Anto, J. M. (1996). Scaling the Spanish version of the Nottingham health profile: Evidence of limited value of item weights. Journal of Clinical Epidemiology, 49, 31-38.
26. Weinfurt, K. P., Willke, R. J., Glick, H. A., Freimuth, W. W., Schulman, K. A. (2000). Relationship between CD4 count, viral burden, and quality of life over time in HIV-1-infected patients. Medical Care, 38, 404-410.
27. Dolan, P., Gudex, C., Kind, P., Williams, A. (1996). The time trade-off method: Results from a general population study. Health Economy, 5, 141-154.
28. Scientific, Advisory Committee of the Medical Outcomes Trust. (2002). Assessing health status and quality-of-life instruments: Attributes and review criteria. Quality of Life Research, 11, 193-205.
29. Wu, A. W., Revicki, D. A., Jacobson, D., Malitz, F. E. (1997). Evidence for reliability, validity and usefulness of the medical outcomes study HIV health survey (MOS-HIV). Quality of Life Research, 6, 481-493.
30. Gill, C. J., Griffith, J. L., Jacobson, D., Skinner, S., Gorbach, S. L., Wilson, I. B. (2002). Relationship of HIV viral loads, CD4 counts, and HAART use to health-related quality of life. Journal of acquired immune deficiency syndromes, 30, 485-492.
31. McHorney, C. A., Ware, J. E Jr, Rogers, W., Raczek, A. E., Lu, J. F. (1992). The validity and relative precision of MOS short- and long-form health status scales and Dartmouth COOP charts. results from the medical outcomes study. Medical Care, 30, MS253-65.
32. McHorney, C. A., Ware, J. E Jr, Raczek, A. E. (1993). The MOS 36-item short-form health survey (SF-36): II. psychometric and clinical tests of validity in measuring physical and mental health constructs. Medical Care, 31, 247-263.
33. Guyatt, GH., Osoba, D., Wu, A. W., Wyrwich, K. W., Norman, G. R. (2002). Clinical Significance Consensus Meeting Group. Methods to explain the clinical significance of health status measures. Mayo Clinic proceedings, 77, 371-383.
34. STATCorp. (2001). Stata Statistical Software: Release 7.0. College Station, TX: Stata Corporation.
35. Walters, S. J., Brazier, J. E. (2005). Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D. Quality of Life Research, 14, 1523-1532.
36. Franzblau, A. N. (1958). A primer of statistics for non-statisticians. New York: Harcourt, Brace.
37. Havranek, E. P., Steiner, J. F. (2005). Valuation of health states in the US versus the UK: Two measures divided by a common language? Medical Care, 43, 201-202.
38. Harrell, F. E, Jr, Lee, K. L., Mark, D. B. (1996). Multivariable prognostic models: Issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Statistics in medicine, 15, 361-387.
39. Shwartz, M, Ash, A. S. (2003). Evaluating risk-adjustment models empirically. In L. I. Iezzoni (Eds.), Risk adjustment for measuring health care outcomes. (3rd ed. pp. 231-273). Chicago, I. L: Health Administration Press.
40. Luo, N., Johnson, J. A., Shaw, J. W., Feeny, D., Coons, S. J. (2005). Self-reported health status of the general adult U.S. population as assessed by the EQ-5D and health utilities index. Medical Care, 43, 1078-1086.
41. Jenkinson, C. (1991). Why are we weighting? A critical examination of the use of item weights in a health status measure. Social Science and Medicine, 32, 1413-1416.
42. McGrath, C., Bedi, R. (2004). Why are we "weighting"? an assessment of a self-weighting approach to measuring oral health-related quality of life. Community Dentistry and Oral Epidemiology, 32, 19-24.
43. Prieto, L., Sacristan, J. A. (2004). What is the value of social values? The uselessness of assessing health-related quality of life through preference measures. BMC Medical Research Methodology, 4, 10.
44. Badia, X., Alonso, J. (1995). Re-scaling the Spanish version of the sickness impact profile: An opportunity for the assessment of cross-cultural equivalence. Journal of Clinical Epidemiology, 48, 949-957.
45. Hunt, S. M. (1987). Cross-cultural variation in the weighting of health statements: A comparison of English and Swedish valuations. Health Policy, 8, 227-235.
46. Ware, J. E, Jr., Gandek, B., Kosinski, M. et al (1998). The equivalence of SF-36 summary health scores estimated using standard and country-specific algorithms in 10 countries: Results from the IQOLA project. Journal of Clinical Epidemiology, 51, 1167-1170.
47. Ubel, P. A., Loewenstein, G., Jepson, C. (2003). Whose quality of life? A commentary exploring discrepancies between health state evaluations of patients and the general public. Quality of Life Research, 12, 599-607.
48. Patrick, D. L., Sittampalam, Y., Somerville, S. M., Carter, W. B., Bergner, M. A (1985). cross-cultural comparison of health status values. American Journal of Public Health, 75, 1402-1407.
49. Bucquet, D., Condon, S., Ritchie, K. (1990). The French version of the Nottingham health profile. A comparison of items weights with those of the source version. Social Science and Medicine, 30, 829-835.
50. Jenkinson, C. (1999). Comparison of UK and US methods for weighting and scoring the SF-36 summary measures. Journal of Public Health Medicine, 21, 372-376.
51. Keller, S. D., Ware, J. E Jr., Bentler, P. M. et al (1998). Use of structural equation modeling to test the construct validity of the SF-36 health survey in ten countries: Results from the IQOLA project. international quality of life assessment. Journal of Clinical Epidemiology, 51, 1179-1188.
52. Byrne, B. M. (2001). Structural Equation Modeling with AMOS: Basic Concepts, Applications, and Programming. Mahwah, NJ: Lawrence Erlbaum Associates.